Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCL2L1 | Q07817 | 18/20 | 0.65 |
| ▸ | BCL2 | P10415 | 15/20 | 0.65 |
| ▸ | BAD | Q92934 | 4/20 | 0.65 |
| ▸ | BCL2L2 | Q92843 | 3/20 | 0.65 |
| ▸ | BCL2L11 | O43521 | 1/20 | 0.65 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.65 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.65 |
| ▸ | ASPH | Q12797 | 1/20 | 0.65 |
| ▸ | VHL | P40337 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19014790 | 0.93 | BCL2L1 (0.77) | BCL2L1BCL2BADBCL2L2BCL2L11 | |
| SCHEMBL22409472 | 0.93 | BCL2L1 (0.77) | BCL2L1BCL2BADBCL2L2BCL2L11 | |
| SCHEMBL19014717 | 0.92 | BCL2L1 (0.69) | BCL2L1BCL2BADBCL2L2BCL2L11 | |
| SCHEMBL19014818 | 0.90 | BCL2L1 (0.66) | BCL2L1BCL2BADBCL2L2BCL2L11 | |
| SCHEMBL19014822 | 0.89 | BCL2L1 (0.62) | BCL2L1BCL2 | |
| SCHEMBL19014815 | 0.89 | BCL2L1 (0.69) | BCL2L1BCL2BADBCL2L2BCL2L11 | |
| SCHEMBL19014788 | 0.89 | BCL2L1 (0.76) | BCL2L1BCL2BADBCL2L2BCL2L11 | |
| SCHEMBL19014816 | 0.88 | BCL2L1 (0.68) | BCL2L1BCL2BADBCL2L2BCL2L11 | |
| SCHEMBL19014912 | 0.87 | BCL2L1 (0.85) | BCL2L1BCL2BADBCL2L2BCL2L11 | |
| SCHEMBL19014780 | 0.87 | BCL2L1 (0.79) | BCL2L1BCL2BADBCL2L2BCL2L11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017101851-A1 | ACYLSULFONAMIDE DERIVATIVES FOR TREATING SENESCENCE-ASSOCIATED DISEASES AND DISORDERS | UNITY BIOTECHNOLOGY, INC. (US) | 2017-06-22 | — | — | WO | disclosed |